Skip to Main

Healthy Living: New Endometrial Cancer Treatment Could Be Life-Changing for Patients

Endometrial cancer, or cancer of the lining of the uterus, is the second-most common form of cancer in women worldwide.

When surgery and chemotherapy don’t work, the five-year survival rate is just 17%.

In today’s Healthy Living, we have more on an FDA approved immunotherapy that experts say may be life-changing for women with advanced endometrial cancer.